Tachikawa Corporation
Tachikawa Corporation (7989.T) Financial Performance & Income Statement Overview
Analyze Tachikawa Corporation (7989.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Tachikawa Corporation (7989.T) Income Statement & Financial Overview
Explore comprehensive income reports for Tachikawa Corporation 7989.T, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $10.51B | $11.43B | $9.81B | $9.90B |
| Cost of Revenue | $5.97B | $6.69B | $5.88B | $5.83B |
| Gross Profit | $4.55B | $4.74B | $3.93B | $4.07B |
| Gross Profit Ratio | $0.43 | $0.41 | $0.40 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $161.00M |
| SG&A Expenses | $3.21B | $3.16B | $3.17B | $3.11B |
| Operating Expenses | $3.21B | $3.32B | $3.17B | $3.27B |
| Total Costs & Expenses | $9.18B | $10.01B | $9.04B | $9.10B |
| Interest Income | $5.93M | $1.92M | $0.00 | $816000.00 |
| Interest Expense | $212000.00 | $100000.00 | $280000.00 | $1000.00 |
| Depreciation & Amortization | $278.12M | $291.60M | $301.77M | $296.28M |
| EBITDA | $1.63B | $1.71B | $1.04B | $1.26B |
| EBITDA Ratio | $0.16 | $0.15 | $0.11 | $0.13 |
| Operating Income | $1.34B | $1.42B | $764.74M | $794.52M |
| Operating Income Ratio | $0.13 | $0.12 | $0.08 | $0.08 |
| Other Income/Expenses (Net) | $18.37M | -$205.67M | -$28.18M | $172.53M |
| Income Before Tax | $1.35B | $1.22B | $736.56M | $967.05M |
| Income Before Tax Ratio | $0.13 | $0.11 | $0.08 | $0.10 |
| Income Tax Expense | $290.97M | $381.39M | $289.57M | $329.24M |
| Net Income | $1.06B | $833.81M | $428.73M | $597.56M |
| Net Income Ratio | $0.10 | $0.07 | $0.04 | $0.06 |
| EPS | $52.87 | $41.74 | $23.22 | $32.37 |
| Diluted EPS | $52.87 | $41.74 | $23.22 | $32.37 |
| Weighted Avg Shares Outstanding | $20.10M | $19.98M | $18.47M | $18.46M |
| Weighted Avg Shares Outstanding (Diluted) | $20.10M | $19.98M | $18.46M | $18.46M |
Over the past four quarters, Tachikawa Corporation demonstrated steady revenue growth, increasing from $9.90B in Q2 2024 to $10.51B in Q1 2025. Operating income reached $1.34B in Q1 2025, maintaining a consistent 13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.63B, reflecting operational efficiency. Net income rose to $1.06B, with EPS at $52.87. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan